Gene · 134
Papers2,244
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,244
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Examining the Role of the Linker in Bitopic N6-Substituted Adenosine Derivatives Acting as Biased Adenosine A1 Receptor Agonists. | J Med Chem | 2022 | 35729775 | PubTator, text mining | PubMed |
| A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients. | Front Oncol | 2022 | 35712480 | PubTator, text mining | PubMed |
| Discovery of a High Affinity Adenosine A1/A3 Receptor Antagonist with a Novel 7-Amino-pyrazolo[3,4-d]pyridazine Scaffold. | ACS Med Chem Lett | 2022 | 35707146 | PubTator, text mining | PubMed |
| Targeting the LSD1-G9a-ER Stress Pathway as a Novel Therapeutic Strategy for Esophageal Squamous Cell Carcinoma. | Research (Wash D C) | 2022 | 35707047 | PubTator, text mining | PubMed |
| Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes. | Noncoding RNA Res | 2022 | 35702574 | PubTator, text mining | PubMed |
| Emerging roles of activating transcription factor (ATF) family members in tumourigenesis and immunity: Implications in cancer immunotherapy. | Genes Dis | 2022 | 35685455 | PubTator, text mining | PubMed |
| The Role of Schwann Cells in Cancer. | Adv Biol (Weinh) | 2022 | 35666078 | PubTator, text mining | PubMed |
| Serum miRNA Profile in Diabetic Patients With Ischemic Heart Disease as a Promising Non-Invasive Biomarker. | Front Endocrinol (Lausanne) | 2022 | 35663309 | PubTator, text mining | PubMed |
| Genomic signatures of the evolution of a diurnal lifestyle in Strigiformes. | G3 (Bethesda) | 2022 | 35640557 | PubTator, text mining | PubMed |
| Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy. | Int J Biol Sci | 2022 | 35637973 | PubTator, text mining | PubMed |
| Design, synthesis and evaluation of amino-3,5-dicyanopyridines and thieno[2,3-b]pyridines as ligands of adenosine A1 receptors for the potential treatment of epilepsy. | Med Chem Res | 2022 | 35634433 | PubTator, text mining | PubMed |
| The Promise of Nanotechnology in Personalized Medicine. | J Pers Med | 2022 | 35629095 | PubTator, text mining | PubMed |
| Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy. | Int J Mol Sci | 2022 | 35628334 | PubTator, text mining | PubMed |
| Adenosine, Adenosine Receptors and Neurohumoral Syncope: From Molecular Basis to Personalized Treatment. | Biomedicines | 2022 | 35625864 | PubTator, text mining | PubMed |
| Cancer-related somatic mutations alter adenosine A1 receptor pharmacology-A focus on mutations in the loops and C-terminus. | FASEB J | 2022 | 35604751 | PubTator, text mining | PubMed |
| The Molecular Basis of Resilience: A Narrative Review. | Front Psychiatry | 2022 | 35599764 | PubTator, text mining | PubMed |
| Silencing miRNA-324-3p protects against cerebral ischemic injury via regulation of the GATA2/A1R axis. | Neural Regen Res | 2022 | 35535903 | PubTator, text mining | PubMed |
| Off-targetP ML: an open source machine learning framework for off-target panel safety assessment of small molecules. | J Cheminform | 2022 | 35525988 | PubTator, text mining | PubMed |
| Unraveling the mechanism of alkaloids from Sophora alopecuroides Linn combined with immune checkpoint blockade in the treatment of non-small cell lung cancer based on systems pharmacology. | Bioorg Med Chem | 2022 | 35468537 | PubTator, text mining | PubMed |
| Integrated analysis of transcriptomic datasets to identify placental biomarkers of spontaneous preterm birth. | Placenta | 2022 | 35462239 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/134/papers?page=20